Steve Wigginton is CEO at Evolent Health, Inc. (EVH). They have made 9 open-market trades across 1 company since 2016, most recently 2017-08-01.
CIK 0001232583
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EVH | 18,411 | $88K |
Shares reported on the most recent Form 4, priced at the 2017-08-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EVH | SELL | 2017-08-01 | 2017-08-03 | $24.64 | $148K | -25.8% | -25.6% | -35.7% |
| EVH | SELL | 2017-07-03 | 2017-07-06 | $25.07 | $150K | +8.3% | -3.4% | -25.0% |
| EVH | SELL · 10b5-1 | 2017-06-06 | 2017-06-08 | $25.75 | $25K | -3.1% | -7.1% | -34.7% |
| EVH | SELL | 2017-06-01 | 2017-06-05 | $24.13 | $145K | -2.5% | -1.0% | -31.3% |
| EVH | SELL | 2017-05-19 | 2017-05-23 | $24.30 | $331K | +11.6% | +10.9% | -26.1% |
| EVH | SELL | 2017-05-01 | 2017-05-03 | $23.10 | $139K | +5.7% | +9.7% | +4.9% |
| EVH | SELL | 2017-04-03 | 2017-04-05 | $23.15 | $139K | -2.9% | +4.5% | +13.8% |
| EVH | SELL · 10b5-1 | 2017-03-03 | 2017-03-07 | $20.20 | $20K | +10.1% | +11.3% | +30.9% |
| EVH | SELL | 2017-03-01 | 2017-03-03 | $20.11 | $121K | +6.0% | +16.2% | +22.7% |
| EVH | SELL | 2017-02-15 | 2017-02-17 | $20.13 | $242K | -0.2% | +5.1% | +12.9% |
| EVH | SELL | 2016-09-14 | 2016-09-15 | $21.54 | $2.0M | -0.7% | +0.3% | -27.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.